Skip to content Skip to footer

Close

Home
Technology
Our Team
Shareholders & Partners
News & Publications
Contact

Founding of the company PROVIREX Genome Editing Therapies GmbH

Fri, 1. November 2019

Founding of the company PROVIREX Genome Editing Therapies GmbH

Post navigation

PROVIREX’s proprietary Brec1 technology enters clinical testing as a first-in-human phase

Fri, 29. November 2019

PROVIREX

PROVIREX
Genome Editing Therapies GmbH

Luruper Hauptstraße 1
22547 Hamburg

Germany

mail@provirex.com

Imprint
Privacy Policy
Disclaimer

SUBSCRIBE

Leave this field empty if you're human:

Copyright © PROVIREX Genome Editing Therapies GmbH 2023

Search for: